TY - JOUR KW - ADP-ribosyl Cyclase 1 KW - Adult KW - Antiretroviral Therapy, Highly Active KW - CD4-Positive T-Lymphocytes KW - CD8-Positive T-Lymphocytes KW - Female KW - Granzymes KW - HIV Infections KW - Humans KW - Immunity, Cellular KW - Immunologic Memory KW - Interferon-gamma KW - Leprosy, Paucibacillary KW - Lymphocyte Activation KW - Male KW - Membrane Glycoproteins KW - Middle Aged KW - Mycobacterium leprae KW - Neuroimmunomodulation KW - Perforin KW - Skin KW - Young Adult AU - Oliveira AL AU - Amadeu TP AU - França Gomes AC AU - Menezes VM AU - Costa Nery JA AU - Pinheiro R AU - Sarno E AB -
It has been reported that the initiation of highly active anti-retroviral therapy (HAART) is associated with the development of reversal reaction (RR) in co-infected HIV/leprosy patients. Nevertheless, the impact of HIV and HAART on the cellular immune response to Mycobacterium leprae (ML) remains unknown. In the present study, we observed that ex vivo peripheral blood mononuclear cells (PBMCs) of both RR and RR/HIV patients presented increased percentages of activated CD4(+) T cells when compared with the healthy individuals (HC) group. The frequency of CD8(+) CD38(+) cells increased in the PBMCs of RR/HIV patients but not in RR patients when compared with the HC group. Both RR and RR/HIV skin lesion cells presented similar percentages of activated CD4(+) cells, but the numbers of activated CD8(+) cells were higher in RR/HIV in comparison to the RR group. The frequency of interferon-γ-producing cells was high in response to ML regardless of HIV co-infection. In ML-stimulated cells, there was an increase in central memory CD4(+) T-cell frequencies in the RR and RR/HIV groups, but an increase in central memory CD8(+) T-cell frequency was only observed in the RR/HIV group. ML increased granzyme B(+) effector memory CD8(+) T-cell frequencies in the RR/HIV PBMCs, but not in the HC and RR groups. Our data suggest that the increased expression of effector memory CD8(+) T cells, together with greater perforin/granzyme B production, could be an additional mechanism leading to the advent of RR in co-infected patients. Moreoever, this increased expression may explain the severity of RR occurring in these patients.
BT - Immunology C1 - http://www.ncbi.nlm.nih.gov/pubmed/23566249?dopt=Abstract CN - OLIVEIRA 2013 DA - 2013 Sep DO - 10.1111/imm.12108 IS - 1 J2 - Immunology LA - eng N2 -It has been reported that the initiation of highly active anti-retroviral therapy (HAART) is associated with the development of reversal reaction (RR) in co-infected HIV/leprosy patients. Nevertheless, the impact of HIV and HAART on the cellular immune response to Mycobacterium leprae (ML) remains unknown. In the present study, we observed that ex vivo peripheral blood mononuclear cells (PBMCs) of both RR and RR/HIV patients presented increased percentages of activated CD4(+) T cells when compared with the healthy individuals (HC) group. The frequency of CD8(+) CD38(+) cells increased in the PBMCs of RR/HIV patients but not in RR patients when compared with the HC group. Both RR and RR/HIV skin lesion cells presented similar percentages of activated CD4(+) cells, but the numbers of activated CD8(+) cells were higher in RR/HIV in comparison to the RR group. The frequency of interferon-γ-producing cells was high in response to ML regardless of HIV co-infection. In ML-stimulated cells, there was an increase in central memory CD4(+) T-cell frequencies in the RR and RR/HIV groups, but an increase in central memory CD8(+) T-cell frequency was only observed in the RR/HIV group. ML increased granzyme B(+) effector memory CD8(+) T-cell frequencies in the RR/HIV PBMCs, but not in the HC and RR groups. Our data suggest that the increased expression of effector memory CD8(+) T cells, together with greater perforin/granzyme B production, could be an additional mechanism leading to the advent of RR in co-infected patients. Moreoever, this increased expression may explain the severity of RR occurring in these patients.
PY - 2013 SP - 47 EP - 60 T2 - Immunology TI - Role of CD8(+) T cells in triggering reversal reaction in HIV/leprosy patients. UR - http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3809705/pdf/imm0140-0047.pdf VL - 140 SN - 1365-2567 ER -